A Breakthrough in Understanding Why Exercise Matters
For years, cancer survivors have heard a consistent message:
Exercise is good for you.
But a critical question has remained:
How—and why—does physical activity help prevent cancer and improve long-term health?
A new large-scale study analyzing over 33,000 individuals has now provided a powerful answer. By examining thousands of proteins circulating in the blood, researchers have identified specific biological changes linked to moderate-to-vigorous physical activity (MVPA)—and these same changes are associated with a lower risk of cancer and other chronic diseases.
This study moves exercise oncology forward in a major way. It shows that exercise is not just associated with better outcomes—it is actively reshaping the biology of your body.
What the Study Found
Researchers identified 220 proteins that change in response to higher levels of physical activity. Many of these proteins are directly involved in processes that influence cancer risk, including:
- Inflammation control
- Metabolism and insulin regulation
- Immune system activity
- Muscle and tissue health
Most importantly, individuals with a stronger “exercise-related protein signature” had a:
👉 13% lower risk of developing cancer
They also showed reduced risk of:
- Cardiovascular disease
- Type 2 diabetes
These conditions often occur together with cancer—a combination known as multimorbidity, which affects a large percentage of cancer survivors.
Why This Matters for Cancer Survivors
This study provides something incredibly important:
biological proof that exercise works.
For cancer survivors, this means:
1. Exercise Targets the Root Causes of Cancer Progression
Physical activity reduces chronic inflammation, improves metabolic health, and strengthens immune function—all of which are critical drivers of cancer growth and recurrence.
2. Exercise Protects Against Other Serious Diseases
About 4 in 10 cancer patients develop another chronic condition such as heart disease or diabetes.
Exercise helps address these risks simultaneously.
3. Exercise Is a Long-Term Survival Strategy
The protein changes observed in this study reflect consistent, ongoing activity, not short-term effort. This reinforces that exercise is a lifelong intervention—not a temporary fix.
What Kind of Exercise Makes a Difference?
The study focused on moderate-to-vigorous physical activity, which includes:
- Brisk walking
- Cycling
- Swimming
- Resistance training
- Structured exercise programs
The key is reaching an intensity that elevates your heart rate and challenges your body.
What This Means for Cancer Care
This research sends a clear message to the oncology community:
Exercise is not optional—it is essential.
It should be:
- Integrated into standard cancer care
- Prescribed alongside treatments
- Supported through structured programs
Exercise is increasingly being recognized as a form of “biologic therapy”—one that patients can actively participate in.
A CancerFitness.org Call to Action
If you are a cancer survivor, this study reinforces something powerful:
👉 You have more control over your health than you may think.
Exercise is one of the most effective tools available to you—not just to feel better, but to change your biology in ways that may reduce future cancer risk and improve survival.
Start Here:
- Aim for at least 150 minutes per week of moderate activity
- Include strength training 2–3 times per week
- Begin slowly and progress safely
- Work with your healthcare team or an exercise professional if needed
Most Important:
Start. Stay consistent. Keep going.
The Bottom Line
This study provides compelling scientific evidence that:
👉 Exercise changes the proteins in your blood in ways that may help prevent cancer and other chronic diseases.
For cancer survivors, that means exercise is not just about fitness—it is about survival, resilience, and long-term health.
Reference: Proteomics signature of moderate-to-vigorous physical activity and risk of multimorbidity of cancer and cardiometabolic diseases. Michael J. Stein, Hansjörg Baurecht, Patricia Bohmann, Reynalda Cordova, Pietro Ferrari, et al. communications medicine, https://doi.org/10.1038/s43856-026-01514-9
